Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020 : report (to accompany H.R. 5534) (including cost estimate of the Congressional Budget Office) |
Pubbl/distr/stampa | [Washington, D.C.] : , : [U.S. Government Publishing Office], , [2020]- |
Descrizione fisica | 1 online resource (volumes) |
Collana | Rept. / 116th Congress, 2d session, House of Representatives |
Soggetto topico |
Medicare - Law and legislation
Kidneys - Diseases - Patients - Care Immunosuppressive agents Pharmaceutical services insurance - Law and legislation - United States Kidneys - Transplantation Managed care plans (Medical care) - United States |
Soggetto genere / forma | Legislative materials. |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020 |
Record Nr. | UNINA-9910715269403321 |
[Washington, D.C.] : , : [U.S. Government Publishing Office], , [2020]- | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Immunosuppression [[electronic resource] ] : new research / / Charles B. Taylor, editor |
Pubbl/distr/stampa | New York, : Nova Science Pub. Inc., 2009 |
Descrizione fisica | 1 online resource (320 p.) |
Disciplina | 615.37 |
Altri autori (Persone) | TaylorCharles B |
Soggetto topico |
Immunosuppression
Immunosuppressive agents |
Soggetto genere / forma | Electronic books. |
ISBN | 1-60876-707-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
""Immunosuppression: New Research""; ""Contents""; ""Preface""; ""Is There a Future for Costimulation Blockade as a Regulatory T-cell Inducing Therapy?""; ""Abstract""; ""Introduction""; ""Costimulation Blockade""; ""Regulatory T-Cells""; ""Conclusion""; ""References""; ""Strategies for T Cell Depletion to Prevent Graft versus Host Disease""; ""Abstract""; ""Introduction""; ""Pharmacological Intervention""; ""T Cell Depletion - An Effective Non-PharmacologicImmunosuppression""; ""Pre �Clinical Models and Early Clinical Studies""; ""Strategies of T Cell Depletion""
""Merits and Problems with TCD""""Haploidentical Transplantation""; ""Strategies to Improve Outcome of Patients with TCell Depletion""; ""Conclusions""; ""References""; ""Leucocyte Intracellular Cytokines in Lung Transplant Patients- A More Physiological Indicator of Immunosuppression than Plasma Drug Levels""; ""Abstract""; ""Introduction""; ""Acute and Chronic Transplant Rejection""; ""Immunosuppression""; ""Conclusion""; ""References""; ""Indications and Management of m-TOR Inhibitors after Liver Transplantation""; ""Abstract""; ""Introduction""; ""Objectives""; ""Material and Methods"" ""Results""""Discussion""; ""References""; ""Evolution of Immunosuppression in Liver Transplantation""; ""Abstract""; ""Abbreviations""; ""Introduction""; ""Evolution of Immunosuppression""; ""Recent Advances in ImmunosuppressionFollowing Liver Transplantation""; ""Conclusion""; ""References""; ""The Role of Pharmacogenomics in Tailoring Immunosuppressive Therapy for Liver Transplant Recipients""; ""Abstract""; ""Introduction""; ""Current Immunosuppressive Drugs""; ""Pharmacogenomics and Drug Metabolism""; ""Genetic Polymorphism and Immunosuppressive Drugs"" ""Limitations of Clinical application of Pharmacogenomics""""Conclusion""; ""References""; ""Immunosuppression Caused by Photochemo- and Photodynamic Therapy: Focus on Photosensitizer Photoproducts""; ""Abstract""; ""Introduction""; ""Suppression of Delayed Type Hypersensitivity (DTH) Reaction by Products of Photosensitizer Photooxidation""; ""Suppression of Contact Hypersensitivity (CHS) by PUVA-Treatment and by Photosensitizer Photoproducts""; ""POP Therapy Is a New Patient-Friendly Photochemotherapy That Requires No UV-A Irradiation of Skin or Blood""; ""Conclusion""; ""References"" ""Sunlight Induced Immunosuppression: A Role for Inflammatory Mediators in the Induction of Suppressor Cells""""Abstract""; ""Introduction""; ""Immunosuppression Only Requires Exposure toLow Doses of UV Radiation""; ""Sunlight Is Immunosuppressive""; ""UV-Induced Regulatory Cells""; ""Factors Involved in the Activationof UV-Regulatory Cells""; ""Dendritic Cells as Mediators of Regulatory T Cell Activation""; ""Mast Cells and the Activation of RegulatoryPopulations in Secondary Lymphoid Tissues""; ""Regulatory B Cells as Facilitatorsof UV-Immunosuppression""; ""Conclusion""; ""References"" ""Immunosuppressive Therapy in Adult to Adult Living-Related Liver Transplantation"" |
Record Nr. | UNINA-9910452202503321 |
New York, : Nova Science Pub. Inc., 2009 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Immunosuppression [[electronic resource] ] : new research / / Charles B. Taylor, editor |
Pubbl/distr/stampa | New York, : Nova Science Pub. Inc., 2009 |
Descrizione fisica | 1 online resource (320 p.) |
Disciplina | 615.37 |
Altri autori (Persone) | TaylorCharles B |
Soggetto topico |
Immunosuppression
Immunosuppressive agents |
ISBN | 1-60876-707-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
""Immunosuppression: New Research""; ""Contents""; ""Preface""; ""Is There a Future for Costimulation Blockade as a Regulatory T-cell Inducing Therapy?""; ""Abstract""; ""Introduction""; ""Costimulation Blockade""; ""Regulatory T-Cells""; ""Conclusion""; ""References""; ""Strategies for T Cell Depletion to Prevent Graft versus Host Disease""; ""Abstract""; ""Introduction""; ""Pharmacological Intervention""; ""T Cell Depletion - An Effective Non-PharmacologicImmunosuppression""; ""Pre �Clinical Models and Early Clinical Studies""; ""Strategies of T Cell Depletion""
""Merits and Problems with TCD""""Haploidentical Transplantation""; ""Strategies to Improve Outcome of Patients with TCell Depletion""; ""Conclusions""; ""References""; ""Leucocyte Intracellular Cytokines in Lung Transplant Patients- A More Physiological Indicator of Immunosuppression than Plasma Drug Levels""; ""Abstract""; ""Introduction""; ""Acute and Chronic Transplant Rejection""; ""Immunosuppression""; ""Conclusion""; ""References""; ""Indications and Management of m-TOR Inhibitors after Liver Transplantation""; ""Abstract""; ""Introduction""; ""Objectives""; ""Material and Methods"" ""Results""""Discussion""; ""References""; ""Evolution of Immunosuppression in Liver Transplantation""; ""Abstract""; ""Abbreviations""; ""Introduction""; ""Evolution of Immunosuppression""; ""Recent Advances in ImmunosuppressionFollowing Liver Transplantation""; ""Conclusion""; ""References""; ""The Role of Pharmacogenomics in Tailoring Immunosuppressive Therapy for Liver Transplant Recipients""; ""Abstract""; ""Introduction""; ""Current Immunosuppressive Drugs""; ""Pharmacogenomics and Drug Metabolism""; ""Genetic Polymorphism and Immunosuppressive Drugs"" ""Limitations of Clinical application of Pharmacogenomics""""Conclusion""; ""References""; ""Immunosuppression Caused by Photochemo- and Photodynamic Therapy: Focus on Photosensitizer Photoproducts""; ""Abstract""; ""Introduction""; ""Suppression of Delayed Type Hypersensitivity (DTH) Reaction by Products of Photosensitizer Photooxidation""; ""Suppression of Contact Hypersensitivity (CHS) by PUVA-Treatment and by Photosensitizer Photoproducts""; ""POP Therapy Is a New Patient-Friendly Photochemotherapy That Requires No UV-A Irradiation of Skin or Blood""; ""Conclusion""; ""References"" ""Sunlight Induced Immunosuppression: A Role for Inflammatory Mediators in the Induction of Suppressor Cells""""Abstract""; ""Introduction""; ""Immunosuppression Only Requires Exposure toLow Doses of UV Radiation""; ""Sunlight Is Immunosuppressive""; ""UV-Induced Regulatory Cells""; ""Factors Involved in the Activationof UV-Regulatory Cells""; ""Dendritic Cells as Mediators of Regulatory T Cell Activation""; ""Mast Cells and the Activation of RegulatoryPopulations in Secondary Lymphoid Tissues""; ""Regulatory B Cells as Facilitatorsof UV-Immunosuppression""; ""Conclusion""; ""References"" ""Immunosuppressive Therapy in Adult to Adult Living-Related Liver Transplantation"" |
Record Nr. | UNINA-9910779522403321 |
New York, : Nova Science Pub. Inc., 2009 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Immunosuppression [[electronic resource] ] : new research / / Charles B. Taylor, editor |
Edizione | [1st ed.] |
Pubbl/distr/stampa | New York, : Nova Science Pub. Inc., 2009 |
Descrizione fisica | 1 online resource (320 p.) |
Disciplina | 615.37 |
Altri autori (Persone) | TaylorCharles B |
Soggetto topico |
Immunosuppression
Immunosuppressive agents |
ISBN | 1-60876-707-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
""Immunosuppression: New Research""; ""Contents""; ""Preface""; ""Is There a Future for Costimulation Blockade as a Regulatory T-cell Inducing Therapy?""; ""Abstract""; ""Introduction""; ""Costimulation Blockade""; ""Regulatory T-Cells""; ""Conclusion""; ""References""; ""Strategies for T Cell Depletion to Prevent Graft versus Host Disease""; ""Abstract""; ""Introduction""; ""Pharmacological Intervention""; ""T Cell Depletion - An Effective Non-PharmacologicImmunosuppression""; ""Pre �Clinical Models and Early Clinical Studies""; ""Strategies of T Cell Depletion""
""Merits and Problems with TCD""""Haploidentical Transplantation""; ""Strategies to Improve Outcome of Patients with TCell Depletion""; ""Conclusions""; ""References""; ""Leucocyte Intracellular Cytokines in Lung Transplant Patients- A More Physiological Indicator of Immunosuppression than Plasma Drug Levels""; ""Abstract""; ""Introduction""; ""Acute and Chronic Transplant Rejection""; ""Immunosuppression""; ""Conclusion""; ""References""; ""Indications and Management of m-TOR Inhibitors after Liver Transplantation""; ""Abstract""; ""Introduction""; ""Objectives""; ""Material and Methods"" ""Results""""Discussion""; ""References""; ""Evolution of Immunosuppression in Liver Transplantation""; ""Abstract""; ""Abbreviations""; ""Introduction""; ""Evolution of Immunosuppression""; ""Recent Advances in ImmunosuppressionFollowing Liver Transplantation""; ""Conclusion""; ""References""; ""The Role of Pharmacogenomics in Tailoring Immunosuppressive Therapy for Liver Transplant Recipients""; ""Abstract""; ""Introduction""; ""Current Immunosuppressive Drugs""; ""Pharmacogenomics and Drug Metabolism""; ""Genetic Polymorphism and Immunosuppressive Drugs"" ""Limitations of Clinical application of Pharmacogenomics""""Conclusion""; ""References""; ""Immunosuppression Caused by Photochemo- and Photodynamic Therapy: Focus on Photosensitizer Photoproducts""; ""Abstract""; ""Introduction""; ""Suppression of Delayed Type Hypersensitivity (DTH) Reaction by Products of Photosensitizer Photooxidation""; ""Suppression of Contact Hypersensitivity (CHS) by PUVA-Treatment and by Photosensitizer Photoproducts""; ""POP Therapy Is a New Patient-Friendly Photochemotherapy That Requires No UV-A Irradiation of Skin or Blood""; ""Conclusion""; ""References"" ""Sunlight Induced Immunosuppression: A Role for Inflammatory Mediators in the Induction of Suppressor Cells""""Abstract""; ""Introduction""; ""Immunosuppression Only Requires Exposure toLow Doses of UV Radiation""; ""Sunlight Is Immunosuppressive""; ""UV-Induced Regulatory Cells""; ""Factors Involved in the Activationof UV-Regulatory Cells""; ""Dendritic Cells as Mediators of Regulatory T Cell Activation""; ""Mast Cells and the Activation of RegulatoryPopulations in Secondary Lymphoid Tissues""; ""Regulatory B Cells as Facilitatorsof UV-Immunosuppression""; ""Conclusion""; ""References"" ""Immunosuppressive Therapy in Adult to Adult Living-Related Liver Transplantation"" |
Record Nr. | UNINA-9910823408303321 |
New York, : Nova Science Pub. Inc., 2009 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Immunosuppressives : advancements, applications and analyses / / Margaret Griffin, editor |
Pubbl/distr/stampa | Hauppauge, NY : , : Nova Science Publishers, Incorporated, , [2017] |
Descrizione fisica | 1 online resource (111 pages) : illustrations |
Disciplina | 615.3/7 |
Collana | Immunology and immune system disorders |
Soggetto topico | Immunosuppressive agents |
ISBN | 1-5361-0844-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910164041803321 |
Hauppauge, NY : , : Nova Science Publishers, Incorporated, , [2017] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Pharmacology of immunosuppression / / Howard J. Eisen, editor |
Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2022] |
Descrizione fisica | 1 online resource (351 pages) : illustrations |
Disciplina | 615.9 |
Collana | Handbook of experimental pharmacology |
Soggetto topico |
Immunosuppression
Immunosuppressive agents Pharmacology |
ISBN |
9783031051180
9783031051173 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910583508803321 |
Cham, Switzerland : , : Springer, , [2022] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Resistance to immunotherapeutic antibodies in cancer : strategies to overcome resistance / / Benjamin Bonavida, editor |
Edizione | [1st ed. 2013.] |
Pubbl/distr/stampa | New York, : Springer, c2013 |
Descrizione fisica | 1 online resource (210 p.) |
Disciplina | 616.994079 |
Altri autori (Persone) | BonavidaBenjamin |
Collana | Resistance to targeted anti-cancer therapeutics |
Soggetto topico |
Cancer - Immunotherapy
Drug resistance in cancer cells Monoclonal antibodies Immunosuppressive agents |
ISBN | 1-4614-7654-2 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Preface -- Introduction and generation of chimeric and humanized mAbs -- mAbs targeted against cancer cells and antibodies targeted against the tumor microenvironment -- Antibodies directed against different major cancers: Effects when used alone or in combination with drugs -- Mechanisms of antibodies-mediated responses, in vitro and in vivo -- Molecular Pathways -- Molecular Signatures -- Identification of resistance targets for intervention -- Various chemicals that can sensitize resistant tumor cells -- Other mAbs -- Proteasome inhibitors -- Divalent mAbs -- Antibodies coupled to chemical inhibitors -- Antibodies coupled to cytokines -- Nanoparticles with mAbs -- Index. |
Record Nr. | UNINA-9910739439503321 |
New York, : Springer, c2013 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|